The Board undertakes wide-ranging consultation on proposals that affect the profession.
Where there are consultations open for input, they will be shown above.
Where there are consultations which have closed, they will be shown under Past Consultations, along with the submissions that were received.
Public consultation on revised registration standard and guidelines
- Endorsement for scheduled medicines registration standard, and
- Guidelines for use of scheduled medicines
Released: 1 February 2017
Closes: 31 March 2017
The Optometry Board of Australia (the Board) is seeking feedback from the profession, stakeholders and the community on a proposed revised endorsement for scheduled medicines registration standard and related guidelines.
The Endorsement for scheduled medicines registration standard (the current registration standard) sets out the requirements for an optometrist to have their registration endorsed for scheduled medicines. The current registration standard was approved by the Australian Health Workforce Ministerial Council (Ministerial Council) and took effect on 1 July 2010.
The Guidelines for endorsement for use of scheduled medicines (the guidelines) outline the Board’s expectations about the use of scheduled medicines by optometrists. The guidelines have previously been revised and the current version took effect in December 2014.
The Board has reviewed the current registration standard and related guidelines in keeping with good regulatory practice and is asking for your feedback.
Highlights of proposed changes
- The proposed revised registration standard and guidelines would be clearer and easier to understand.
- The Board-approved list of scheduled medicines currently attached to the standard will:
- be attached to the guidelines, and
- be replaced with a description of classes of scheduled medicines to which the endorsement applies in the standard.
- The Board will endorse the registration of optometrists as being qualified to administer, obtain, possess, prescribe, supply or use medicines, in accordance with relevant state and territory legislation, in the following classes: topical schedule 2, 3 or 4 medicines for the purposes of the practice of optometry.
Potential benefits of proposed changes
- The proposed changes continue to protect the public by ensuring that only suitably qualified and competent practitioners can have their registration endorsed for scheduled medicines.
- By transferring the list to the guidelines, the Board will be enabled to revise the list (after consultation) in a more responsive and efficient manner. For example, changes may be needed to:
- delete scheduled medicines from the list when the medicine has been removed from the market, including due to patient safety reasons, and
- add newly available medicines to the list and improve public accessibility to current medicines that endorsed optometrists are qualified to prescribe.
- The proposed changes will provide greater clarity and consistency by aligning the language in the standard with that of relevant state and territory drugs and poisons legislation.
The Board is inviting comments on the proposed revised registration standard and guidelines.
To provide feedback, please provide written submissions:
Submissions will generally be published to encourage discussion and inform the community and stakeholders, unless you request otherwise. There may be circumstances under which submissions may not be published. Please refer to the consultation paper for details of how submissions will be treated. Submissions received in response to a consultation are published under Past Consultations.
* You are welcome to supply a PDF file of your feedback in addition to the Word (or equivalent) file, however we request that you do supply a text or Word file. As part of an effort to meet international website accessibility guidelines, AHPRA and National Boards are striving to publish documents in accessible formats (such as Word), in addition to PDFs. More information about this is available on the Accessibility page on the AHPRA website.